Hirobriz Breezhaler
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hirobriz Breezhaler, covering 2025-11-18 to 2025-11-18. Get the full timeline:
Most recent: EMA Authorised: Hirobriz Breezhaler (indacaterol maleate) — Novartis Europharm Limited